|
Echo IQ (ASX: EIQ) chief operating officer Philip Woolff joins Small Caps to discuss the company’s plans to rapidly commercialise its artificial intelligence-based cardiovascular diagnostic technology.
The company was recently selected to take part in the US-based HeartX accelerator program, which helps fast-track deployment of cardiovascular innovations.
To fund the development of its technology, Echo IQ recently raised A$3.27 million and secured a further US$150,000 in funding under the HeartX accelerator program.
Article: https://smallcaps.com.au/echo-iq-fast-track-us-expansion-ai-cardiovascular-diagnostic-technology/
For more information on Echo IQ: https://smallcaps.com.au/stocks/EIQ/ See omnystudio.com/listener for privacy information. |